Methadone for refractory restless legs syndrome
Identifieur interne : 003850 ( Main/Exploration ); précédent : 003849; suivant : 003851Methadone for refractory restless legs syndrome
Auteurs : William G. Ondo [États-Unis]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-03.
English descriptors
- KwdEn :
- Adult, Aged, Aged, 80 and over, Analgesics, Opioid (administration & dosage), Analgesics, Opioid (therapeutic use), Drug Administration Schedule, Female, Humans, Male, Methadone (administration & dosage), Methadone (therapeutic use), Middle Aged, Restless Legs Syndrome (drug therapy), augmentation, dopaminergics, methadone, restless legs syndrome.
- MESH :
- chemical , administration & dosage : Analgesics, Opioid, Methadone.
- chemical , therapeutic use : Analgesics, Opioid, Methadone.
- drug therapy : Restless Legs Syndrome.
- Adult, Aged, Aged, 80 and over, Drug Administration Schedule, Female, Humans, Male, Middle Aged.
Abstract
Most cases of restless legs syndrome (RLS) initially respond well to dopaminergic agonists. However, an unknown percentage of patients is intolerant of dopaminergic adverse events, initially or subsequently refractory, or develops limiting augmentation. We administered methadone 5 to 40 mg/day (final dose, 15.6 ± 7.7) to 29 RLS patients who failed dopaminergics. They were currently taking or had previously tried 5.9 ± 1.7 (range, 3–9) different medications for RLS and 2.9 ± 0.8 (range, 2–4) different dopaminergics. Of the 27 patients who met inclusion criteria, 17 have remained on methadone for 23 ± 12 months (range, 4–44 months) at a dose of 15.5 ± 7.7 mg/day; 2 dialysis RLS patients died while on methadone, and 8 stopped the treatment (5 for adverse events, 2 for lack of efficacy, and 1 for logistical reasons). All patients who remain on methadone report at least a 75% reduction in symptoms, and none have developed augmentation. Methadone should be considered in RLS patients with an unsatisfactory dopaminergic response. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20359
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002C55
- to stream Istex, to step Curation: 002C55
- to stream Istex, to step Checkpoint: 002258
- to stream PubMed, to step Corpus: 003194
- to stream PubMed, to step Curation: 003194
- to stream PubMed, to step Checkpoint: 003063
- to stream Ncbi, to step Merge: 001107
- to stream Ncbi, to step Curation: 001107
- to stream Ncbi, to step Checkpoint: 001107
- to stream Main, to step Merge: 004F35
- to stream Main, to step Curation: 003850
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Methadone for refractory restless legs syndrome</title>
<author><name sortKey="Ondo, William G" sort="Ondo, William G" uniqKey="Ondo W" first="William G." last="Ondo">William G. Ondo</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:4D639917C3D66D247999F7C3E6F89969F9E02985</idno>
<date when="2005" year="2005">2005</date>
<idno type="doi">10.1002/mds.20359</idno>
<idno type="url">https://api.istex.fr/document/4D639917C3D66D247999F7C3E6F89969F9E02985/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002C55</idno>
<idno type="wicri:Area/Istex/Curation">002C55</idno>
<idno type="wicri:Area/Istex/Checkpoint">002258</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Ondo W:methadone:for:refractory</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:15580610</idno>
<idno type="wicri:Area/PubMed/Corpus">003194</idno>
<idno type="wicri:Area/PubMed/Curation">003194</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003063</idno>
<idno type="wicri:Area/Ncbi/Merge">001107</idno>
<idno type="wicri:Area/Ncbi/Curation">001107</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001107</idno>
<idno type="wicri:doubleKey">0885-3185:2005:Ondo W:methadone:for:refractory</idno>
<idno type="wicri:Area/Main/Merge">004F35</idno>
<idno type="wicri:Area/Main/Curation">003850</idno>
<idno type="wicri:Area/Main/Exploration">003850</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Methadone for refractory restless legs syndrome</title>
<author><name sortKey="Ondo, William G" sort="Ondo, William G" uniqKey="Ondo W" first="William G." last="Ondo">William G. Ondo</name>
<affiliation wicri:level="1"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Baylor College of Medicine, Houston Texas</wicri:regionArea>
<wicri:noRegion>Houston Texas</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2005-03">2005-03</date>
<biblScope unit="vol">20</biblScope>
<biblScope unit="issue">3</biblScope>
<biblScope unit="page" from="345">345</biblScope>
<biblScope unit="page" to="348">348</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">4D639917C3D66D247999F7C3E6F89969F9E02985</idno>
<idno type="DOI">10.1002/mds.20359</idno>
<idno type="ArticleID">MDS20359</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Analgesics, Opioid (administration & dosage)</term>
<term>Analgesics, Opioid (therapeutic use)</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Methadone (administration & dosage)</term>
<term>Methadone (therapeutic use)</term>
<term>Middle Aged</term>
<term>Restless Legs Syndrome (drug therapy)</term>
<term>augmentation</term>
<term>dopaminergics</term>
<term>methadone</term>
<term>restless legs syndrome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Methadone</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Methadone</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Restless Legs Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Most cases of restless legs syndrome (RLS) initially respond well to dopaminergic agonists. However, an unknown percentage of patients is intolerant of dopaminergic adverse events, initially or subsequently refractory, or develops limiting augmentation. We administered methadone 5 to 40 mg/day (final dose, 15.6 ± 7.7) to 29 RLS patients who failed dopaminergics. They were currently taking or had previously tried 5.9 ± 1.7 (range, 3–9) different medications for RLS and 2.9 ± 0.8 (range, 2–4) different dopaminergics. Of the 27 patients who met inclusion criteria, 17 have remained on methadone for 23 ± 12 months (range, 4–44 months) at a dose of 15.5 ± 7.7 mg/day; 2 dialysis RLS patients died while on methadone, and 8 stopped the treatment (5 for adverse events, 2 for lack of efficacy, and 1 for logistical reasons). All patients who remain on methadone report at least a 75% reduction in symptoms, and none have developed augmentation. Methadone should be considered in RLS patients with an unsatisfactory dopaminergic response. © 2004 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><country name="États-Unis"><noRegion><name sortKey="Ondo, William G" sort="Ondo, William G" uniqKey="Ondo W" first="William G." last="Ondo">William G. Ondo</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003850 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003850 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:4D639917C3D66D247999F7C3E6F89969F9E02985 |texte= Methadone for refractory restless legs syndrome }}
This area was generated with Dilib version V0.6.23. |